HOLDINGS
CREDENCE MEDSYSTEMS
Medical Technology and Drug Delivery
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners.
Credence MedSystems has changed the paradigm for drug manufacturers commercializing an injectable drug in a differentiated delivery system. The award-winning Companion Safety Syringe System combines a fully compliant, best-in-class injectable drug delivery system with a vastly simplified path to market for our pharma/biotech partners. This is called Innovation Without Change because we offer the innovation of the final device without the change that customarily accompanies combination product development.
For the end-user, the Companion provides integrated automatic needle retraction, syringe reuse prevention and other critical safety and usability features. For the drug manufacturer, the regulatory and development path is vastly simplified and the supply chain is de-risked because the Companion is built onto existing primary package components.
The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. Across the product family, the user performs the injection and receives end-of-dose cues. Then, passively and automatically, the needle retracts into the syringe barrel and the syringe is permanently disabled.
Credence is under the care of a seasoned team with extensive experience founding, leading and growing successful companies in the medical technology and drug delivery space.
Credence MedSystems has a strategic investment from one of the world's leading pharmaceutical companies Novartis, strategic collaborations with SCHOTT AG and has won grants from the Bill & Melinda Gates Foundation.
CURE PHARMACEUTICAL
Cure Pharmaceutical is a preeminent developer and manufacturer of the most advanced oral thin film (CureFilm™) on the market today with an industry leading full service cGMP manufacturing facility.
PROSETTA BIOSCIENCES
Prosetta Biosciences, Inc. is biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).
SILVERSTREAM
SilverStream was formed in 2014 as an alternative financing vehicle for emerging miners, within a precious metals streaming structure, focusing on a clear and defined leverage to precious metals for our shareholders.